Salvinorin A (1), a neoclerodane diterpene from the hallucinogenic mint Salvia divinorum, is the only known non-nitrogenous and specific kappa-opioid agonist. Several structural congeners of 1 isolated from Salvia splendens (2 - 8) together with a series of semisynthetic derivatives (9 - 24), some of which possess a pyrazoline structural moiety (9, 19 - 22), have been tested for affinity at human mu, delta, and kappa opioid receptors. None of these compounds showed high affinity binding to these receptors. However, 10 showed modest affinity for kappa receptors suggesting other naturally neoclerodanes from different Salvia species may possess opioid affinity.
Salvinorin A (1), a n class="Chemical">neoclerodanediterpene from the hallucinogenic mint Salvia divinorum, is the only known non-nitrogenous and specific kappa-opioid agonist. Several structural congeners of 1 isolated from Salvia splendens (2 - 8) together with a series of semisynthetic derivatives (9 - 24), some of which possess a pyrazoline structural moiety (9, 19 - 22), have been tested for affinity at human mu, delta, and kappa opioid receptors. None of these compounds showed high affinity binding to these receptors. However, 10 showed modest affinity for kappa receptors suggesting other naturally neoclerodanes from different Salvia species may possess opioid affinity.
Authors: Wayne W Harding; Matthew Schmidt; Kevin Tidgewell; Pavitra Kannan; Kenneth G Holden; Christina M Dersch; Richard B Rothman; Thomas E Prisinzano Journal: Bioorg Med Chem Lett Date: 2006-04-18 Impact factor: 2.823
Authors: Richard B Rothman; Daniel L Murphy; Heng Xu; Jonathan A Godin; Christina M Dersch; John S Partilla; Kevin Tidgewell; Matthew Schmidt; Thomas E Prisinzano Journal: J Pharmacol Exp Ther Date: 2006-10-23 Impact factor: 4.030
Authors: David Y W Lee; Minsheng He; Leelakrishna Kondaveti; Lee-Yuan Liu-Chen; Zhongze Ma; Yulin Wang; Yong Chen; Jian-Guo Li; Cecile Beguin; William A Carlezon; Bruce Cohen Journal: Bioorg Med Chem Lett Date: 2005-10-01 Impact factor: 2.823
Authors: Heng Xu; John S Partilla; Xiaoying Wang; John M Rutherford; Kevin Tidgewell; Thomas E Prisinzano; Laura M Bohn; Richard B Rothman Journal: Synapse Date: 2007-03 Impact factor: 2.562
Authors: Wayne W Harding; Kevin Tidgewell; Nathan Byrd; Howard Cobb; Christina M Dersch; Eduardo R Butelman; Richard B Rothman; Thomas E Prisinzano Journal: J Med Chem Date: 2005-07-28 Impact factor: 7.446
Authors: Katherine M Prevatt-Smith; Kimberly M Lovell; Denise S Simpson; Victor W Day; Justin T Douglas; Peter Bosch; Christina M Dersch; Richard B Rothman; Bronwyn Kivell; Thomas E Prisinzano Journal: Medchemcomm Date: 2011-12 Impact factor: 3.597
Authors: Jin-Hee Kim; Jeffrey R Deschamps; Richard B Rothman; Christina M Dersch; John E Folk; Kejun Cheng; Arthur E Jacobson; Kenner C Rice Journal: Bioorg Med Chem Date: 2011-04-22 Impact factor: 3.641
Authors: Malliga R Iyer; Yong Sok Lee; Jeffrey R Deschamps; Christina M Dersch; Richard B Rothman; Arthur E Jacobson; Kenner C Rice Journal: Eur J Med Chem Date: 2012-01-20 Impact factor: 6.514
Authors: Fuying Li; Jason A Deck; Christina M Dersch; Richard B Rothman; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice Journal: Eur J Med Chem Date: 2012-10-30 Impact factor: 6.514
Authors: Hwan Jung Lim; Christina M Dersch; Richard B Rothman; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice Journal: Eur J Med Chem Date: 2013-06-25 Impact factor: 6.514
Authors: Malliga R Iyer; Richard B Rothman; Christina M Dersch; Arthur E Jacobson; Kenner C Rice Journal: Bioorg Med Chem Date: 2013-04-03 Impact factor: 3.641
Authors: Yi Zhang; Yong Sok Lee; Richard B Rothman; Christina M Dersch; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice Journal: J Med Chem Date: 2009-12-10 Impact factor: 7.446
Authors: Denise S Simpson; Kimberly M Lovell; Anthony Lozama; Nina Han; Victor W Day; Christina M Dersch; Richard B Rothman; Thomas E Prisinzano Journal: Org Biomol Chem Date: 2009-07-14 Impact factor: 3.876